CD8A and B-cell chronic lymphocytic leukemia: Contribution of CD4 and/or CD8 was examined by coculture of CLL cells with either HD CD4+ or CD8+ or CD4+ and CD8+ together (1:1 ratio) in the presence of teclistamab for 96 hours.